NASDAQ:STIM
Neuronetics, Inc.
Neuronetics, Inc.'s revenue grew 99.2% in fiscal 2025 to $149.2M while operating margin rose to −21.1%, its highest in 10 years. Free cash flow was −$21.2M, −14.2% of revenue, and the diluted share count rose 107.8%.Summary generated from Neuronetics, Inc.'s SEC filings. Latest annual report filed Mar 17, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$149.2M
Revenue growth+99.2%
Revenue, 5-yr CAGR+24.8%
Gross margin48.5%
Operating margin−21.1%
Net margin−26.1%
ROIC−39.9%
Return on equity−155.7%
Debt / equity2.94
Free cash flow−$21.2M
FCF margin−14.2%
Share count change+107.8%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 55 | 65 | 71 | 75 | 149 |
| Operating income | −28 | −35 | −31 | −35 | −31 |
| Net income | −31 | −37 | −30 | −44 | −39 |
| Free cash flow | −30 | −34 | −34 | −32 | −21 |
Recent filings
- 8-KDirector or officer change
Aug 17, 2026 - 4Insider transaction report
Aug 17, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 11, 2026 - 8-KResults of operations and financial condition
Aug 11, 2026 - 4Insider transaction report
Jul 23, 2026 - 8-KDirector or officer change
Jul 20, 2026 - 8-KDirector or officer change
Jun 23, 2026 - 8-KResults of a shareholder vote
May 29, 2026